PRVAQT34Privia Health Group, Inc.·NASDAQ
21.47+0.89%
TA
Loading chart...
Screen all →
Snapshot
Index—P/E97.59EPS (ttm)0.22Insider Own—Shs Outstand127.73MPerf Week-1.65%
Market Cap2.74BForward P/E51.50EPS next Y0.42Insider Trans-0.44%Shs Float108.95MPerf Month4.99%
Enterprise Value2.42BPEG2.67EPS next Q0.09Short Float4.60%Perf Quarter-10.39%
Income28.00MP/S1.16EPS this Y95.53%Short Ratio4.00Perf Half Y-11.61%
Sales2.36BP/B—EPS next Y61.97%ROA0.00%Short Interest5.01MPerf YTD-9.45%
Book/sh6561.08P/C0.01EPS next 5Y36.49%ROE0.01%52W High28.82 -25.50%Perf Year-11.65%
Cash/sh3227.02P/FCF—EPS past 3/5Y— -9.71%ROIC0.00%52W Low18.92 13.48%Perf 3Y-1.65%
Dividend Est.—EV/EBITDA—Sales past 3/5Y16.09% 21.04%Gross Margin7.61%Volatility3.15% 2.90%Perf 5Y-4.62%
Dividend TTM—EV/Sales—EPS Y/Y TTM87.47%Oper. Margin1.90%ATR (14)0.64Perf 10Y—
Dividend Ex-Date—Quick Ratio1.62Sales Y/Y TTM24.11%Profit Margin1.19%RSI (14)49.07Recom2.09
Dividend Gr. 3/5Y—Current Ratio1.62EPS Q/Q—SMA20-1.62%Beta0.74Target Price28.00
Payout0.00%Debt/Eq0.01Sales Q/Q21.50%SMA502.77%Rel Volume1.01Prev Close21.28
Employees1,226LT Debt/Eq0.01EarningsNov 05SMA200-5.19%Avg Volume1.24MPrice21.47
IPO DateApr 28, 2021Option/ShortYes / YesEPS/Sales Surpr.3.89% 5.91%Net Debt/EBITDA-5933.24Volume1,255,481Change0.89%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-07-26ReiteratedCanaccord GenuityBuy$34 → $32
May-26-26ReiteratedBarclaysEqual Weight$22 → $24
Apr-08-26ReiteratedEvercore ISI GroupOutperform$22 → $26
Feb-26-26ReiteratedJefferies$32
Feb-26-26ReiteratedPiper SandlerOverweight$40 → $36
Jan-09-26ResumedRBC CapitalOutperform$31
Jan-06-26ReiteratedWolfe Research$31
Nov-12-25ReiteratedCanaccord GenuityBuy$30 → $34
Oct-09-25ReiteratedBarclaysEqual Weight$19 → $22
Aug-29-25ReiteratedJMP SecuritiesMarket Outperform$29 → $30
Latest News· Times ET
Nov-02-26
Oct-27-26
Oct-22-26
Oct-19-26
Oct-10-26
Oct-08-26
Oct-05-26
Oct-04-26
Sep-30-26
Sep-19-26
Sep-14-26
Sep-08-26
Sep-03-26
Aug-26-26
Company

Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive suite of services. These include technology and population health tools designed to streamline independent providers' workflows; a Management Services Organization (MSO) that alleviates administrative tasks, freeing providers to focus on clinical care; a single-TIN medical group, which bolsters payer negotiations, facilitates clinical integration, and aligns financial incentives; an Accountable Care Organization (ACO) designed to engage patients, reduce inefficient utilization, and improve care coordination and patient quality metrics, thereby advancing value-based care; and a network connecting providers with new patient populations and enabling custom contracts with purchasers and payers. Founded in 2007, the company's headquarters are located in Arlington, Virginia. Privia Health Group, Inc. was formerly a subsidiary of Brighton Health Group Holdings, LLC.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,3582,1231,7361,658—————
Cost of Goods Sold Incl. D&A2,1791,9131,5601,496—————
Gross Profit180209177162—————
Selling, General and Administrative Excl. Other49,738165153134—————
Research and Development
0000—————
Other Operating Expense-49,6031077—————
Operating Income44341721—————
Interest Expense
0000—————
Unusual Expense
—————————
Non-Operating Income (Expense)1110118—————
Net Income Before Taxes56442829—————
Income Taxes2314118—————
Consolidated Net Income28231423—————
Net Income From Continuing Operations35301721—————
Net Income28231423—————
EPS (Recurring)0.220.190.120.20—————
EPS (Basic, Before Extraordinaries)0.220.190.120.20—————
EPS (Diluted)0.220.180.110.19—————
EBITDA68543536—————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio97.59131.72177.73121.21—————
Price To Sales Ratio1.151.361.341.63—————
Gross Margin7.639.8410.209.77—————
Operating Margin1.871.600.981.27—————
Net Margin1.191.080.811.39—————
Shares Outstanding126122119117—————
Market Capitalization2,7052,8932,3262,695—————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$29.45$26.53$23.60$20.68$17.75● Close Price0.00M1.64M3.29M4.93M6.57MUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Mountcastle DavidEVP & Chief Financial OfficerJul 09 '26Sale27.6721,275588,679164,853Jul 13
Mountcastle DavidEVP & Chief Financial OfficerJul 07 '26Sale27.5760016,542186,128Jul 09
Morris Matthew ShawnDirectorJul 06 '26Sale27.2453,7221,463,38768,188Jul 07
Morris Matthew ShawnDirectorJul 06 '26Option Exercise2.0053,722107,444130,373Jul 07
Mountcastle DavidEVP & Chief Financial OfficerJul 02 '26Sale27.5024,734680,185186,728Jul 07
Morris Matthew ShawnDirectorJul 02 '26Option Exercise2.0059,037118,074135,688Jul 07
Morris Matthew ShawnDirectorJul 02 '26Sale27.3359,0371,613,48176,651Jul 07
Morris Matthew ShawnDirectorJul 01 '26Sale26.7082,6752,207,72876,651Jul 02
Morris Matthew ShawnDirectorJul 01 '26Option Exercise2.0082,675165,350159,326Jul 02
Morris Matthew ShawnDirectorJun 30 '26Option Exercise2.0052,823105,646129,474Jul 02
Morris Matthew ShawnDirectorJun 30 '26Sale25.7252,8231,358,60876,651Jul 02
Morris Matthew ShawnDirectorJun 29 '26Option Exercise2.0063,212126,424139,863Jun 30
Morris Matthew ShawnDirectorJun 29 '26Sale25.3363,2121,601,16076,651Jun 30
Morris Matthew ShawnDirectorJun 26 '26Option Exercise2.0088,110176,220164,761Jun 30
Mountcastle DavidEVP & Chief Financial OfficerJun 26 '26Option Exercise2.0026,09352,186228,658Jun 30
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.